Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-27 · accession 0001765581-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-03 | 2025-02-27 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | A - Grant | $0.00 | +30.8K | 470.6K | +7% | $0 | |
| 2025-03-03 | 2025-03-03 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | S - Sale | $144.25 | -6,500 | 464.1K | -1% | -$937.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-02-27 | A | A | 30,814 | $0.00 | 470,558 | D | — | — | |
| 2 | Common | Ordinary Shares | 2025-03-03 | S | D | 6,500 | $144.25 | 464,058 | D | — | — |